Lethal toxin actions and their consequences

被引:30
作者
Hanna, P [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Microbiol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA
关键词
D O I
10.1046/j.1365-2672.1999.00891.x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
After entry of infectious anthrax spores into the body, host-specific signals induce spore germination, outgrowth of vegetative bacilli and the expression of lethal toxin and other virulence factors. Anthrax lethal toxin (LeTx) is a virulence factor responsible for the major pathologies seen during systemic anthrax infections. Injection of sterile LeTx into test animals mimics the shock and sudden death seen during active bacterial infections. Once large levels of LeTx are produced within the body, destruction of bacteria by administration of antibiotics is usually unsuccessful. The LeTx is believed to be secreted into the bloodstream where it circulates freely throughout the body and binds and enters host cells. Once in the cytoplasm, the lethal factor acts as a zinc-metalloprotease disrupting normal homoeostatic functions. Macrophages are a uniquely sensitive cell type that seem to be vital global mediators of toxin-induced pathologies. Removal of macrophages from mice renders them insensitive to LeTx challenge. Low levels of lethal toxin induce macrophage production, in vitro , of the shock-inducing cytokines TNF and 11-1 beta. Higher levels of LeTx cause over-production of reactive oxygen intermediates, bursting of macrophages and release of mediators of shock. We believe; that agents capable of blocking key steps of the lethal toxin cascade may prove useful in combating anthrax pathologies.
引用
收藏
页码:285 / 287
页数:3
相关论文
共 15 条
[1]   CONSTRUCTION AND CHARACTERIZATION OF A PROTECTIVE ANTIGEN-DEFICIENT BACILLUS-ANTHRACIS STRAIN [J].
CATALDI, A ;
LABRUYERE, E ;
MOCK, M .
MOLECULAR MICROBIOLOGY, 1990, 4 (07) :1111-1117
[2]   Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor [J].
Duesbery, NS ;
Webb, CP ;
Leppla, SH ;
Gordon, VM ;
Klimpel, KR ;
Copeland, TD ;
Ahn, NG ;
Oskarsson, MK ;
Fukasawa, K ;
Paull, KD ;
Vande Woude, GF .
SCIENCE, 1998, 280 (5364) :734-737
[3]  
FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123
[4]   Lethal factor active-site mutations affect catalytic activity in vitro [J].
Hammond, SE ;
Hanna, PC .
INFECTION AND IMMUNITY, 1998, 66 (05) :2374-2378
[5]   ON THE ROLE OF MACROPHAGES IN ANTHRAX [J].
HANNA, PC ;
ACOSTA, D ;
COLLIER, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (21) :10198-10201
[6]  
HANNA PC, 1994, MOL MED, V1, P7
[7]  
HANNA PC, 1998, TOPCIS MICROBIOL IMM, V225, P13
[8]   ANTHRAX TOXIN LETHAL FACTOR CONTAINS A ZINC METALLOPROTEASE CONSENSUS SEQUENCE WHICH IS REQUIRED FOR LETHAL TOXIN ACTIVITY [J].
KLIMPEL, KR ;
ARORA, N ;
LEPPLA, SH .
MOLECULAR MICROBIOLOGY, 1994, 13 (06) :1093-1100
[9]  
Leppla S. H., 1995, Bacterial toxins and virulence factors in disease., P543
[10]  
Lincoln R., 1970, MICROBIAL TOXINS, P361